The PCI Choice Trial: a Pilot Randomized Trial of a Decision Aid for Patients With Stable Coronary Artery Disease
| Status: | Completed |
|---|---|
| Conditions: | Angina, Angina, Peripheral Vascular Disease, Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/21/2016 |
| Start Date: | November 2012 |
| End Date: | June 2014 |
Despite several large clinical trials clearly establishing that coronary revascularization
(i.e. percutaneous coronary intervention - PCI) does not prolong survival or prevent
myocardial infarction (MI) for stable coronary artery disease (CAD), patients with stable
angina continue to believe that PCI is performed to improve these outcomes. Additionally,
recent concerns have emerged of overuse of PCI among patients with little or no angina. Thus
there is a compelling need to share with patients the risks and benefits of PCI prior to
treatment to reach an informed decision.
This study is designed to answer the question of whether a decision aid can improve patient
knowledge, decisional conflict and patient satisfaction with decision-making compared to
usual care for the treatment of stable angina.
(i.e. percutaneous coronary intervention - PCI) does not prolong survival or prevent
myocardial infarction (MI) for stable coronary artery disease (CAD), patients with stable
angina continue to believe that PCI is performed to improve these outcomes. Additionally,
recent concerns have emerged of overuse of PCI among patients with little or no angina. Thus
there is a compelling need to share with patients the risks and benefits of PCI prior to
treatment to reach an informed decision.
This study is designed to answer the question of whether a decision aid can improve patient
knowledge, decisional conflict and patient satisfaction with decision-making compared to
usual care for the treatment of stable angina.
Inclusion Criteria:
- Diagnosis of stable angina - As judge by clinician, eligible for medication therapy
or PCI - agree to be available for follow-up survey 3 months after treatment decision
Exclusion Criteria:
- has major communication barrier (severe hearing/vision impairment, dementia, cannot
communicate with clinician in English)
We found this trial at
1
site
Click here to add this to my saved trials
